Mackenzie Financial
NVCR icon

Mackenzie Financial’s NovoCure NVCR Stock Holding History

Mackenzie Financial’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-66,152
Closed -$1.18M – 1798
2025
Q2 		$1.18M Buy
+66,152
New +$1.15M ﹤0.01% 973
2025
Q1 		– Sell
-6,820
Closed -$203K – 1759
2024
Q4 		$203K Buy
+6,820
New +$144K ﹤0.01% 1562
2022
Q1 		– Sell
-12,078
Closed -$907K – 1476
2021
Q4 		$907K Buy
12,078
+4,620
+62% +$464K ﹤0.01% 921
2021
Q3 		$866K Buy
7,458
+3,282
+79% +$496K ﹤0.01% 927
2021
Q2 		$926K Buy
+4,176
New +$812K ﹤0.01% 891
2018
Q2 		– Sell
-23,600
Closed -$514K – 1042
2018
Q1 		$514K Buy
+23,600
New +$508K ﹤0.01% 729

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Mackenzie Financial's NVCR Position: Q3 2025 in Review

Mackenzie Financial sold out of NovoCure (NVCR) in Q3 2025, closing a stake of 66,152 shares — an estimated $1.18M sold.

Mackenzie Financial first reported a position in NVCR in Q1 2018 and held it in 6 quarters. The position peaked at $1.18M in Q2 2025. 244 funds tracked by Wall St. Rank hold NVCR as of Q3 2025.

  • Mackenzie Financial reported no remaining NovoCure position as of Q3 2025 after selling out during the quarter.
  • Mackenzie Financial sold 66,152 NovoCure shares in Q3 2025, an estimated $1.18M.
  • Mackenzie Financial first reported a position in NovoCure in Q1 2018 and held it in 6 quarters.
  • Mackenzie Financial's NovoCure position peaked at $1.18M in Q2 2025.
  • 244 funds tracked by Wall St. Rank held NovoCure as of Q3 2025.

Based on Mackenzie Financial's 13F filing for Q3 2025, filed 13 Nov 2025.